Evidence map›Paper›PMID 34643678›Full record

ArticleAmerican journal of clinical pathology2022

Teleclinical Microbiology: An Innovative Approach to Providing Web-Enabled Diagnostic Laboratory Services in Syria.

Nabil Karah, Konstantinos Antypas, Anas Al-Toutanji, Usama Suveyd, Rayane Rafei, Louis-Patrick Haraoui, Wael Elamin, Monzer Hamze, Aula Abbara, Daniel D Rhoads and 2 more

Abstract read
In one paragraph

Article in American journal of clinical pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nabil KarahDepartment of Molecular Biology and Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.ORCID 0000-0001-8867-658X
Konstantinos AntypasSINTEF Digital, Oslo, Norway.
Anas Al-ToutanjiBiochemical Science and Technology Department, Gaziantep Üniversitesi, Gaziantep, Turkey.
Usama SuveydZooteknik Department, Çukurova Üniversitesi, Gaziantep, Turkey.
Rayane RafeiLaboratoire Microbiologie Santé et Environnement, Doctoral School of Sciences and Technology, Faculty of Public Health, Lebanese University, Tripoli, Lebanon.
Louis-Patrick HaraouiDepartment of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.
Wael ElaminG42 Healthcare, Abu Dhabi, United Arab Emirates.
Monzer HamzeLaboratoire Microbiologie Santé et Environnement, Doctoral School of Sciences and Technology, Faculty of Public Health, Lebanese University, Tripoli, Lebanon.
Aula AbbaraDepartment of Infection, Imperial College, London, UK.
Daniel D RhoadsDepartment of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0002-7636-5191
Liron PantanowitzDepartment of Pathology, University of Michigan, Ann Arbor, MI, USA.
Bernt Eric UhlinDepartment of Molecular Biology and Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.ORCID 0000-0002-2991-8072

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTelemedicine can compensate for the lack of health care specialists in response to protracted humanitarian crises. We sought to assess the usability of a teleclinical microbiology (TCM) program to provide diagnostic services in a hard-to-reach region of Syria.

methodsA semimobile station was equipped with conventional micrograph and macrograph digital imaging systems. An electronic platform (Telemicrobiology in Humanitarian Crises, TmHC) was created to facilitate sharing, interpreting, and storing the results. A pilot study was conducted to identify the bacterial species and antimicrobial susceptibility pattern of 74 urinary clinical isolates. An experience survey was conducted to capture the feedback of 8 participants in the program.

resultsThe TmHC platform (https://sdh.ngo/tmhc/) enabled systematic transmission of the laboratory records and co-interpretation of the results. The isolates were identified as Escherichia coli (n = 61), Klebsiella pneumoniae (n = 12), and Proteus mirabilis(n = 1). All the isolates were multidrug resistant. The performance of our TCM module was rated 4 (satisfying) and 5 (very satisfying) by 6 and 2 users, respectively. Data security of and cost-effectiveness were the main perceived concerns.

conclusionsAlthough we encountered several context-related obstacles, our TCM program managed to reach a highly vulnerable population of 4 million people confined in the northwest region of Syria.

Indexed as

Klebsiella pneumoniaeProteus mirabilisAnti-Bacterial AgentsDiagnostic ServicesHumansMicrobial Sensitivity TestsPilot ProjectsSyriaAnti-Bacterial AgentsAntimicrobial resistanceConflict medicineTelemedicineTelepathologyUrinalysis

Identifiers

PMID34643678
PMCPMC8973258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.